![Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital](https://www.baincapital.com/sites/default/files/news/Areteia_0.png)
Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding | Bain Capital
![EcoVadis Secures $500M Investment to Usher in New Era of Sustainability-Led Business Decisions | General Atlantic EcoVadis Secures $500M Investment to Usher in New Era of Sustainability-Led Business Decisions | General Atlantic](https://www.generalatlantic.com/wp-content/uploads/2022/06/ecovadis-2.jpg)
EcoVadis Secures $500M Investment to Usher in New Era of Sustainability-Led Business Decisions | General Atlantic
![New Era in the Alternative Investment Fund Industry through Tokenisation | Deloitte Luxembourg | Real Estate and Private Equity news digest New Era in the Alternative Investment Fund Industry through Tokenisation | Deloitte Luxembourg | Real Estate and Private Equity news digest](https://www2.deloitte.com/content/dam/Deloitte/lu/Images/infographics/lu-traditional-fund-tokenised-structure.png)